Zalcman G - Search Results

1

Diagnostic value of quantitative assessment of cardiac ¹⁸F-fluoro-2-deoxyglucose uptake in suspected cardiac sarcoidosis.

Lebasnier A, Legallois D, Bienvenu B, Bergot E, Desmonts C, Zalcman G, Agostini D, Manrique A. Lebasnier A, et al. Among authors: zalcman g. Ann Nucl Med. 2018 Jun;32(5):319-327. doi: 10.1007/s12149-018-1250-3. Epub 2018 Mar 20. Ann Nucl Med. 2018. PMID: 29560563

2

Efficiency of 18F-FDG and 99mTc-depreotide SPECT in the diagnosis of malignancy of solitary pulmonary nodules.

Halley A, Hugentobler A, Icard P, Porret E, Sobrio F, Lerochais JP, Bouvard G, Zalcman G, Agostini D. Halley A, et al. Among authors: zalcman g. Eur J Nucl Med Mol Imaging. 2005 Sep;32(9):1026-32. doi: 10.1007/s00259-005-1812-1. Epub 2005 May 5. Eur J Nucl Med Mol Imaging. 2005. PMID: 15877227 Clinical Trial.

3

[Management of malignant pleural effusion].

Zalcman G, Lechapt E, Bergot E. Zalcman G, et al. Rev Prat. 2007 Mar 15;57(5):513-23. Rev Prat. 2007. PMID: 17583136 Review. French.

4

Sarcoidosis.

Bergot E, Paparel P, Zalcman G. Bergot E, et al. Among authors: zalcman g. N Engl J Med. 2008 Mar 27;358(13):1404; author reply 1404-5. N Engl J Med. 2008. PMID: 18376441 No abstract available.

5

Breast-cancer stromal cells with TP53 mutations.

Zalcman G, Bergot E, Hainaut P. Zalcman G, et al. N Engl J Med. 2008 Apr 10;358(15):1635-6; author reply 1636. N Engl J Med. 2008. PMID: 18411429 No abstract available.

6

Gefitinib plus docetaxel in non-small-cell lung cancer.

Zalcman G, Bergot E. Zalcman G, et al. Lancet. 2009 Feb 14;373(9663):541; author reply 542. doi: 10.1016/S0140-6736(09)60192-6. Lancet. 2009. PMID: 19217981 No abstract available.

7

Phosphodiesterase inhibitors for pulmonary hypertension.

Bergot E, Magnier R, Zalcman G. Bergot E, et al. Among authors: zalcman g. N Engl J Med. 2010 Feb 11;362(6):559; author reply 560. doi: 10.1056/NEJMc0912127. N Engl J Med. 2010. PMID: 20147727 No abstract available.

8

Integrating biomarkers into clinical trials: methodological issues for a new paradigm in nonsmall cell lung cancer.

Zalcman G, Bergot E, Creveuil C, Levallet G, Lechapt E. Zalcman G, et al. Curr Opin Oncol. 2011 Jan;23(1):106-11. doi: 10.1097/CCO.0b013e3283412eca. Curr Opin Oncol. 2011. PMID: 21076302 Review.

9

[Prognostic and predictive biomarkers in non-small cell lung cancers. From conditioned registrations to routine molecular mapping of lung cancers: Methodological issues].

Bergot E, Levallet G, Creveuil C, Lechapt E, Zalcman G. Bergot E, et al. Among authors: zalcman g. Presse Med. 2011 Apr;40(4 Pt 1):379-88. doi: 10.1016/j.lpm.2011.01.016. Epub 2011 Mar 3. Presse Med. 2011. PMID: 21376511 Review. French.

10

Pulmonary hypertension in patients with neurofibromatosis type I.

Montani D, Coulet F, Girerd B, Eyries M, Bergot E, Mal H, Biondi G, Dromer C, Hugues T, Marquette C, O'Connell C, O'Callaghan DS, Savale L, Jaïs X, Dorfmüller P, Begueret H, Bertoletti L, Sitbon O, Bellanné-Chantelot C, Zalcman G, Simonneau G, Humbert M, Soubrier F. Montani D, et al. Among authors: zalcman g. Medicine (Baltimore). 2011 May;90(3):201-211. doi: 10.1097/MD.0b013e31821be2b7. Medicine (Baltimore). 2011. PMID: 21512413 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

304 results

Search Page